Related by context. All words. (Click for frequent words.) 61 Glioblastoma Multiforme 61 Acute Myelogenous Leukemia AML 60 CYT# potent vascular disrupting 60 AA Amyloidosis 60 TTF Therapy 60 hematological diseases 59 kidney urologic 59 metastatic pancreatic 59 aflibercept VEGF Trap 59 recurrent glioblastoma multiforme 59 indolent follicular non 59 cisplatin gemcitabine 59 recurrent glioma 59 SYMMETRY SM trial 59 juvenile myelomonocytic leukemia 59 Bayer HealthCare Onyx Pharmaceuticals 58 recurrent NSCLC 58 Acute Myelogenous Leukemia 58 Aflibercept 58 recurrent glioblastoma 58 leukemia AML 58 Myelodysplastic Syndrome 58 standard chemotherapy regimen 58 Hodgkin lymphoma HL 58 osteolytic bone disease 58 FUSILEV enhances 58 LymphoStat B belimumab 58 unresectable tumors 58 metastatic renal 58 Acute Myeloid Leukaemia AML 58 combining voreloxin 58 Philadelphia Chromosome Positive 58 hypercholesterolemic patients 58 HER2 positive metastatic breast 57 recurrent malignant glioma 57 steroid refractory GvHD 57 relapsed MM 57 myocardial infarction ventricular fibrillation 57 Myelofibrosis 57 INSPIRE Trial Phase III 57 Infusion reactions 57 carcinoma mCRC 57 delayed CINV 57 Menopausal hormone therapy 57 ZACTIMA TM ZD# 57 Hypertensive adverse reactions 57 Idiopathic pulmonary fibrosis 57 decompensated liver disease 57 primary immunodeficiency PI 57 refractory colorectal cancer 57 recurrent metastatic ovarian cancer 57 Acute myeloid leukemia 57 invasive candidiasis 57 idiopathic pulmonary fibrosis IPF 57 Dupuytren Disease 57 Ribavirin causes 57 CINQUIL 57 Budesonide foam crofelemer 57 metastatic colorectal carcinoma 57 synovial cell 57 prostate cancer CRPC 57 refractory chronic lymphocytic 57 alfa 2a 57 Non Hodgkins lymphoma 57 interstitial pulmonary fibrosis 57 inoperable pancreatic cancer 57 occlusion PAO 57 IRX 2 57 intravenous belinostat 57 Hepatocellular Carcinoma HCC 56 Hormone Refractory Prostate Cancer 56 Diffuse Intrinsic Pontine Glioma 56 diffuse intrinsic pontine glioma 56 Dementia Related Psychosis 56 osteopetrosis 56 IV metastatic melanoma 56 smoldering myeloma 56 unresectable Stage III 56 mycosis fungoides 56 gastrointestinal GI motility disorders 56 boys Khoran Brown 56 recombinant PSMA vaccine 56 stage IIIb IV 56 Morquio Syndrome 56 Graft Versus Host 56 Acute Myeloid Leukaemia 56 Chronic lymphocytic leukemia 56 dexanabinol 56 chronic GVHD 56 benign prostatic hypertrophy BPH 56 Burkitt Lymphoma 56 oral mucositis OM 56 Alessandro Riva 56 anthracycline taxane 56 PLX STROKE targeting 56 Chronic Lymphocytic Leukemia CLL 56 oral ridaforolimus 56 chemotherapy cisplatin 56 Pegloticase 56 minimally symptomatic 56 delayed onset CINV 56 evaluating T DM1 56 genetic neuromuscular disorder 56 personalized cellular immunotherapy 56 Lung transplantation 56 thalidomide Thalomid 56 relapsing remitting MS RRMS 56 PEGINTRON REBETOL combination 56 S. aureus bloodstream infections 56 paclitaxel Taxol R 56 lymphoma leukemia 56 gemcitabine chemotherapy 56 leukemia lymphoma multiple myeloma 56 Ewings sarcoma 56 parathyroid carcinoma 56 prostate cancer HRPC 56 metastatic castration resistant 56 dirucotide MBP# 56 riociguat 56 lenalidomide Revlimid R 56 renal failure interstitial lung 56 musculoskeletal metabolic 55 Albuferon albinterferon alfa 2b 55 Percutaneous vertebroplasty 55 Hurler syndrome 55 Wilm Tumor 55 spinal metastases 55 ALS Amyotrophic Lateral Sclerosis 55 PCNSL 55 registrational Phase 55 gastrointestinal mucositis 55 receiving XGEVA 55 hemophagocytic lymphohistiocytosis 55 morphometric vertebral fractures 55 TNF antagonist 55 indolent NHL 55 unresectable liver cancer 55 Teriflunomide 55 elacytarabine 55 Acute Myeloid Leukemia 55 resistant hormone refractory 55 Cariprazine 55 Acute Leukemia 55 malignant pleural mesothelioma 55 R lenalidomide 55 Leber Hereditary Optic Neuropathy 55 Adjuvant chemotherapy 55 pharmacogenomic translational research 55 Renal impairment 55 fallopian tube carcinoma 55 gastrointestinal stromal tumor 55 metastatic bone 55 chronic granulomatous disease 55 Lactic acidosis 55 CTAP# Capsules 55 HCV NS5B polymerase 55 Folfox 55 Zenvia ™ 55 including acne photodamage 55 medulla blastoma 55 Waldenstrom macroglobulinemia 55 Cerebral Amyloid Angiopathy 55 Relapsing Remitting MS 55 alveolar rhabdomyosarcoma 55 Juvenile Idiopathic Arthritis 55 de novo kidney transplant 55 psoriatic arthritis PsA 55 R sorafenib tablets 55 Mantle Cell Lymphoma 55 erlotinib Tarceva ® 55 phase IIb study 55 allogeneic HSCT 55 mapatumumab 55 Ceflatonin R 55 Ewing sarcoma bone 55 chronic renal disease 55 acute myelogenous 55 evaluating picoplatin 55 relapsed refractory multiple myeloma 55 Wilms Tumor 55 rhabdoid 55 TTR amyloidosis 55 EndoTAGTM 1 55 hypophosphatasia 55 class mGluR5 inhibitor 55 taxane chemotherapy administered 55 tonsillar cancer 55 steroid refractory 55 Eculizumab 55 advanced carcinoid 55 CD# mAb 55 neutropenia dehydration dyspnea 55 proliferative retinopathy 55 docetaxel Taxotere ® 55 advanced hepatocellular carcinoma 55 paclitaxel poliglumex 55 macular degeneration diabetic retinopathy 55 investigational monoclonal antibody 55 myelogenous leukemia 54 TNF antagonist therapy 54 ipsilateral breast 54 Ewings Sarcoma 54 refractory metastatic 54 refractory gout 54 pancreatic NET 54 galiximab 54 ZACTIMA 54 smoldering multiple myeloma 54 Idiopathic Pulmonary Fibrosis IPF 54 invasive aspergillosis 54 ThermoDox R 54 known dihydropyrimidine dehydrogenase 54 sorafenib tablets 54 Myelodysplastic Syndrome MDS 54 pain palliation 54 including eniluracil ADH 54 relapsed AML 54 membranous nephritis 54 familial amyloidotic polyneuropathy FAP 54 Glufosfamide 54 Osteosarcoma 54 debilitating autoimmune 54 follicular Non Hodgkin 54 Soft Tissue Sarcoma 54 relapsed Acute Myeloid 54 infliximab monotherapy 54 HGS ETR1 mapatumumab 54 dasatinib Sprycel ® 54 Leber Congenital Amaurosis LCA 54 pulmonary hypertension PH 54 metastatic HRPC 54 thymoma 54 AA amyloidosis 54 thrombotic disorders 54 unresectable malignant mesothelioma UMM 54 Colorectal Cancer CRC 54 Randomized Double blind 54 SJIA 54 Malignant glioma 54 non resectable 54 Meets Primary Endpoint 54 patella dislocation 54 severe aplastic anemia 54 pulmonary fungal infections 54 Alagille syndrome 54 undergoing elective percutaneous 54 axitinib 54 PITX2 methylation 54 unresectable stage 54 Surgical resection 54 non metastatic osteosarcoma 54 lumiliximab 54 Idiopathic Pulmonary Fibrosis 54 rituximab refractory follicular 54 forodesine 54 irinotecan chemotherapy 54 pediatric malignancies 54 Wegener granulomatosis 54 anthracyclines taxanes 54 mCRC patients 54 active ankylosing spondylitis 54 antithrombotic therapy 54 papillary renal cell carcinoma 54 Crofelemer budesonide foam 54 evaluating tivozanib 54 muscular dystrophy cystic fibrosis 54 metastatic colorectal 54 Xcytrin R 54 fine Schannep 54 FOLFOX4 54 EDEMA3 trial 54 refractory myeloma 54 sapacitabine CYC# 54 Epratuzumab 54 stage IIIb 54 psoriasis psoriatic arthritis 54 equivocal appendicitis 54 osteoporotic compression fractures 54 neoadjuvant treatment 53 pancreatic adenocarcinoma 53 rALLy clinical trial 53 Immune Reconstitution Syndrome 53 Fanconi syndrome 53 cisplatin chemotherapy 53 medically inoperable 53 included exfoliative dermatitis 53 LymphoStat B TM 53 sorafenib Nexavar 53 Proxinium TM 53 Brentuximab Vedotin SGN 53 hematological malignancy 53 hepatocellular cancer 53 Vitrasert ® 53 SNT-MC#/idebenone 53 dyskeratosis congenita 53 bone marrow reticulin deposition 53 ELACYT 53 maximally tolerated lipid lowering 53 MELAS 53 chronically immunosuppressed solid 53 systemic anaplastic large 53 commercialize deforolimus 53 previously untreated follicular 53 opioid induced constipation OIC 53 lymphoblastic lymphoma 53 Doxil ® 53 debilitating complication 53 Wilms tumors 53 colorectal cancer liver metastases 53 Ankylosing spondylitis 53 advanced epithelial ovarian 53 untreated metastatic pancreatic 53 recurrent glioblastoma multiforme GBM 53 imatinib therapy 53 thymic carcinoma 53 evaluating Prochymal 53 Annamycin 53 Telik logo TELINTRA 53 ACTEMRA TM 53 Ketotransdel TM 53 receiving chemoradiation therapy 53 relapsed multiple myeloma 53 non metastatic resectable 53 Acute lymphocytic leukemia 53 HQK 53 Proxinium 53 PNP inhibitor 53 oral prodrug 53 trastuzumab Herceptin ® 53 refractory indolent non 53 diseases osteoarthritis osteoporosis 53 Acute Renal Failure 53 dizziness imbalance 53 mitoxantrone plus 53 intra arterial chemotherapy 53 Vitrasert R 53 MAGE A3 ASCI 53 IV melanoma 53 relapsed leukemia 53 MCSP respectively 53 Chronic Myelogenous Leukemia CML 53 enzastaurin 53 radiation chemoradiation 53 pancytopenia 53 CIMZIA ™ 53 BRAF inhibitor 53 nasal pharyngeal cancer 53 mCRC acneform rash 53 prolonged cytopenias 53 dermatologic reactions 53 pelvic malignancies 53 Relapsed Refractory Aggressive 53 symptomatic hyponatremia 53 BCG refractory carcinoma 53 deCODE ProstateCancer TM 53 underwent resection 53 opioid bowel dysfunction 53 venous stasis ulcers 53 sunitinib malate 53 gastroenterology neurology 53 cirrhosis liver failure 53 diseases bone metastasis 53 serologically active systemic lupus 53 oral rehydration IV 53 metastatic gastric 53 relapsed GBM 53 Amgen Neulasta R 53 Combivir Kivexa 53 Chronic HCV infection 53 IMPACT DCM 53 psychological counseling Carstoiu 53 metastatic GIST 53 HRPC 53 Renal Cell Carcinoma RCC 53 Unstable Angina 53 schizophrenia CIAS 53 idiopathic thrombocytopenic purpura 53 hormone refractory 53 IV NSCLC 53 Empatic ™ 53 Fludarabine 53 refractory Hodgkin 53 Ewing Sarcoma rare 53 AVN# Phase 53 Prochymal TM 53 YONDELIS 53 papillary carcinoma form 53 myeloproliferative neoplasms 53 Pemetrexed 53 Anthracycline 53 LHON 53 osteoarthritis rheumatoid arthritis 53 Krabbe Disease 53 cardio metabolic diseases 53 Lis Franc injury 53 chronic thromboembolic pulmonary 53 Aeolus Pharmaceuticals Announces 53 dacarbazine DTIC 53 TNFerade ™ 53 metastatic lung cancer 52 myeloproliferative disorders 52 Second Pivotal Phase 52 post thrombotic syndrome 52 progressive metastatic prostate 52 immunodeficiencies 52 Wilm tumor 52 prednisone prednisolone plus 52 CRMD# 52 Vicinium TM 52 idiopathic thrombocytopenic purpura ITP 52 T Cell Lymphoma 52 intravesical infusion therapy 52 postoperative chemotherapy 52 Romiplostim 52 transplantation HCT 52 assessing T DM1 52 haematologic 52 Advanced Melanoma 52 novel therapeutic antibodies 52 lupus hepatitis C 52 stage IIIB IV 52 refractory NSCLC 52 Wiskott Aldrich Syndrome 52 acyclovir Lauriad R 52 cytoreductive surgery 52 paroxysmal nocturnal hemoglobinuria 52 GI GVHD common 52 related CMV Retinitis 52 Mucositis 52 targeting miR 52 psoriasis rheumatoid arthritis 52 Dr. Assa Amit 52 myotonic muscular dystrophy 52 manufactures minimally invasive 52 IBS C 52 CIPN 52 erythema nodosum 52 osteogenic sarcoma 52 relapsing multiple sclerosis 52 KRN# 52 opsoclonus myoclonus syndrome 52 heparin induced thrombocytopenia 52 paliperidone ER 52 metastatic androgen independent 52 acute leukemias 52 OncoVex 52 Acute myelogenous leukemia 52 chemoradiotherapy 52 Corona crewmembers 52 pancreas colon 52 Duchenne Muscular Dystrophy DMD 52 interstitial cystitis IC 52 refractory CLL 52 B Cell Lymphoma 52 Fludara ® 52 relapsed SCLC 52 anthracycline containing 52 Cholangiocarcinoma 52 Radical prostatectomy 52 thoracic aortic disease 52 intra abdominal infections 52 ® lenalidomide 52 metastatic CRPC 52 myelodysplastic syndrome MDS 52 immuno inflammatory diseases 52 Pelizaeus Merzbacher disease 52 stage IIIB 52 MKC# MT 52 metastatic bladder 52 samalizumab 52 gastrointestinal stromal tumor GIST 52 nasopharyngeal cancer 52 orally inhaled migraine 52 catheter occlusion 52 Simulect 52 mRCC 52 progressive neurodegenerative 52 Class IIIB IV 52 carcinoid tumors 52 Vascugel 52 Langerhans cell histiocytosis 52 refractory angina 52 diabetic kidney 52 completely resected 52 constipation OIC 52 colorectal lung 52 heavily pretreated 52 Diabetic Macular Edema DME 52 T1c 52 metastatic kidney 52 Alvine Pharmaceuticals 52 Chiari malformation 52 leukemia ALL 52 soft tissue sarcomas 52 gastrointestinal toxicities 52 Treatment Shows Promise 52 GSK# [002] 52 gastrointestinal stromal 52 NATRECOR ® 52 RANK Ligand inhibitor 52 haematological cancers 52 Pulmonary fibrosis 52 antibody MAb 52 infectious diseases autoimmune diseases 52 cancer mCRC 52 Zemplar Capsules 52 opioid induced bowel dysfunction 52 Chronic HCV 52 STRIDE PD 52 Leukemias 52 Pyridorin 52 severe oral mucositis 52 thetreatment 52 docetaxel Taxotere R 52 Idiopathic pulmonary fibrosis IPF 52 Diabetic Ulcers 52 glioblastoma brain tumor 52 tumor angiogenesis inhibitors 52 pomalidomide 52 refractory AML 52 Enzastaurin 52 lupus nephritis 52 chronic myeloid 52 oral rivaroxaban 52 hyperphenylalaninemia HPA due 52 SPRYCEL ® 52 somatostatin analog 52 MEK inhibitor RDEA# 52 neuropathic pain spasticity 52 Sudhir Agrawal D.Phil 52 palliative radiotherapy 52 post herpetic neuralgia PHN 52 recurrent metastatic 52 Naive Patients 52 midstage clinical 52 acetonide FA 52 metastatic renal cell 52 palifermin 52 lymphocytic leukemia 52 tramiprosate Alzhemed TM 52 bile duct cancers 52 NASH Huntington 52 Stereotactic Body Radiation Therapy 52 pancreatic colon 52 vismodegib 52 CTEPH 52 basal cell carcinoma BCC 52 Enzyme Replacement Therapy 52 investigational HCV polymerase 52 lumbar disk herniation 52 polyarticular 52 Juvenile Rheumatoid Arthritis 52 Ozarelix 52 acute myocarditis 52 fatal neurodegenerative disorder 52 neuroendocrine cancers 52 metastatic malignant melanoma 52 invasive fungal infection 52 Critical Limb Ischemia CLI 52 AKT inhibitor 52 Skin grafting 52 SinuNase TM 52 Chronic pancreatitis 52 acute mania 52 eritoran 52 Tardive dyskinesia 52 Alocrest 52 known sulfonamide allergy 52 severe hepatic dysfunction 52 unstable angina UA 52 ovarian lung 52 refractory ovarian cancer 52 psychiatric disorders ATI 52 BY WILLA J. 52 eosinophilic asthma 52 cell carcinoma RCC 52 atypical hemolytic uremic syndrome 52 nonsmall cell lung cancer 52 Cell Non Hodgkin 52 necrotizing enterocolitis NEC 52 asymptomatic metastatic 52 neuro degenerative disorder 52 Nephrogenic Systemic Fibrosis NSF 52 treat chronic sinusitis 52 genitourinary GU 52 delivers fluocinolone acetonide FA 52 AEG# 51 intracranial haemorrhage 51 structure infections ABSSSI 51 NOMID 51 Sanfilippo Syndrome 51 non lifethreatening 51 serine protease inhibitor CU# 51 Cerebril TM 51 oropharyngeal candidiasis OPC 51 Myocarditis 51 non hodgkin lymphoma 51 Chronic Myeloid Leukemia 51 radiochemotherapy 51 biliary tract cancer 51 aerosolized AAT 51 acute promyelocytic leukemia APL 51 cytogenetic responses 51 Diffuse Large B 51 Lou Gherig Disease 51 cyclophosphamide doxorubicin vincristine 51 oral clodronate 51 relapsed CLL 51 modified glutathione analog 51 Kit CD# positive 51 Friedreich Ataxia 51 lung cancer NSCLC 51 metastatic melanoma 51 adjuvant systemic 51 precursor acute lymphoblastic 51 tibial plateau fracture 51 NAGS deficiency 51 juvenile myoclonic epilepsy 51 Oral Calcitonin 51 polyneuropathy HIV DSP 51 hormone refractory prostate cancer 51 Carcinoid Syndrome 51 relapsed ovarian cancer 51 posterior uveitis 51 antirheumatic 51 DMD DMSc 51 Scheuermann kyphosis 51 SHPT 51 HuMax EGFr 51 atherothrombotic events 51 metastatic malignant 51 intracerebral haemorrhage 51 ischemic colitis 51 angiogenesis inhibition 51 lupus scleroderma 51 hepatitis C viral infection 51 Exherin TM 51 metastatic colorectal cancer 51 diagnosed GBM 51 immune thrombocytopenic purpura 51 rheumatoid arthritis osteoarthritis ankylosing 51 Chronic Myelogenous Leukemia 51 mycophenolate mofetil MMF 51 AML Leukemia 51 blastic 51 aldehyde dehydrogenase ALDH2 deficiency 51 poststroke depression 51 squamous histology 51 immune thrombocytopenic purpura ITP 51 Crohns disease 51 extrapleural pneumonectomy 51 Acute Radiation Syndrome ARS 51 significant cytopenia eg 51 osteosarcoma rare 51 liposarcoma 51 Initiates Phase II 51 tizanidine hydrochloride short 51 mycophenolate mofetil 51 keloid scarring 51 multi kinase inhibitor 51 Lennox Gastaut syndrome 51 Psoriatic arthritis 51 autosomal dominant polycystic kidney 51 Relapsing remitting MS 51 radiographic outcomes 51 locoregional recurrence 51 Non Hodgkin 51 lymphoma CTCL 51 TORISEL 51 allogeneic hematopoietic cell 51 leukemia CML 51 ER CHOP 51 EGFR expressing 51 Prodarsan R 51 NLX P# 51 sprained sternoclavicular joint 51 Initiates Enrollment 51 paroxysmal nocturnal hemoglobinuria PNH 51 intravascular hemolysis 51 capecitabine Xeloda 51 naïve HCV 51 SUTENT ® 51 acadesine 51 hypertrichosis occurred 51 pertuzumab 51 Dacogen injection 51 Afatinib 51 Inhaled nitric oxide 51 Diamond Blackfan Anemia 51 receiving antibiotics intravenously 51 metastatic liver 51 Deforolimus 51 NovaVision VRT 51 advanced HER2 positive 51 K ras mutations 51 candidates Azedra TM 51 myelofibrosis polycythemia vera 51 Golimumab 51 Sezary syndrome 51 right quad tendonosis 51 relapsed acute lymphoblastic 51 ruptured patellar tendon 51 Endologix Powerlink System 51 Safinamide 51 standard chemotherapy regimens 51 infection progressive multifocal 51 radiolabeled TM# 51 Rituxan infusion 51 neratinib 51 CVP cyclophosphamide vincristine 51 chronic idiopathic thrombocytopenic purpura 51 metformin accumulation 51 sodium thiosulfate STS 51 Immune reconstitution syndrome 51 Intravenous immunoglobulin 51 recurrent herpes labialis 51 Degarelix 51 symptomatic aortic stenosis 51 GEM OS1 51 Prognostic factors 51 nonalcoholic steatohepatitis 51 leukemia CLL 51 relapsed refractory aggressive 51 R Saizen R 51 Fx #A 51 urothelial cancer 51 adalimumab Humira 51 cutaneous T 51 mild hepatic impairment 51 Severe VOD 51 Traumatic Brain Injury TBI 51 carcinoid tumor 51 cytoreduction 51 medullary thyroid cancer 51 ependymoma 51 either acutely decompensated 51 Talabostat 51 granted Ortec 51 Pervasive Developmental Disorder 51 potent triglyceride lowering 51 metastatic CRC 51 immunocompetent adults 51 basiliximab 51 Aztreonam lysine 51 treating chronic myeloid 51 lymphomas leukemias 51 primary pulmonary hypertension 51 Pulmonary hypertension 51 unruptured aneurysm 51 GI motility disorders 51 dual endothelin receptor antagonist 51 photo ablating 51 drug metabolism bioavailability 51 Glioblastoma Multiforme GBM 51 pancreatic islet cell 51 Combination REOLYSIN R 51 TOFUTTI products 51 Hsp# Inhibitor 51 pegylated interferon peg IFN 51 bronchopulmonary dysplasia BPD 51 induce remission 51 visceral metastases 51 Pruvel TM 51 hemorrhagic pancreatitis 51 neuromuscular spasm 51 chronic ITP patients 51 mCRC 51 GERD migraine headaches 51 postoperative atrial fibrillation 51 ankylosing spondylitis AS 51 osteosarcoma bone 51 AAG geldanamycin analog 51 systemic mastocytosis 51 MGN# 51 targeted immunotherapies 51 untreated CLL 51 superficial bladder cancer 51 PhotoPoint R 51 allogenic stem cell 51 Evoltra ® 51 Vidofludimus 51 Belldegrun 51 diabetic retinopathy DR 51 microsphere therapy 51 Systemic lupus 51 CP CPPS 51 docetaxel chemotherapy 51 hematologic disorders 51 ADVEXIN therapy 51 histologically confirmed 51 evaluate ZFP Therapeutic 51 clinically localized prostate 51 Friedreich Ataxia FRDA 51 Budd Chiari syndrome 51 multiple sclerosis cerebral palsy 51 common neurovascular complication 50 ACZ# 50 chronic constipation CC 50 neuronal ceroid lipofuscinosis NCL 50 curative resection 50 resistant ovarian cancer 50 metastatic renal cell carcinoma 50 Amyotrophic lateral sclerosis ALS 50 Uterine Cancer 50 Dyskinesia 50 Perforomist ™ Inhalation Solution 50 acute promyelocytic leukemia 50 Onco TCS 50 leukopenia pancytopenia thrombocytopenia 50 CBLC# 50 KRAS mutant tumors 50 Leber congenital amaurosis LCA 50 superficial basal cell carcinoma 50 Adjuvant therapy 50 MGd 50 skin itched 50 MabCampath 50 differentiated thyroid 50 Eisenmenger syndrome 50 Aggrastat ® tirofiban hydrochloride 50 Oracea TM 50 Prodarsan 50 grade serous ovarian 50 antiangiogenesis therapies 50 MKC# MKC# PP 50 ELADUR ™ 50 gastrointestinal stromal tumors GIST 50 leukemia myeloma 50 Golfer Ballesteros 50 Hemorrhagic Stroke caused 50 Hodgkin Disease 50 Phase 1b clinical trials 50 cortical dysplasia 50 SCCHN 50 Bronchopulmonary Dysplasia 50 oral mTOR inhibitor 50 esthesioneuroblastoma rare form 50 myelodysplastic syndromes MDS 50 leiomyosarcoma 50 multiorgan 50 neurological sequelae 50 Abiraterone Acetate 50 nonalcoholic steatohepatitis NASH 50 XL# SAR# 50 systemic fungal infections 50 DIPG 50 proliferative diseases 50 cryptogenic cirrhosis 50 Major Depressive Disorder MDD 50 hormone refractory metastatic prostate 50 TNF Tumor Necrosis Factor 50 lung esophageal 50 colorectal liver 50 Candida infection 50 relapsing MS 50 lung fibrosis 50 pan histone deacetylase 50 Fibrin MB 50 intravenous antibiotic therapy 50 CMV disease 50 FDA Approves Novel 50 Tarvacin Anti Cancer 50 ProMune 50 cell lymphoma CTCL 50 dimensional conformal radiation 50 cirrhotic CHC monoinfected patients 50 postoperative AF 50 leukemia multiple myeloma 50 Carfilzomib 50 tyrosine kinase inhibitors TKIs 50 TEMODAL 50 acute GVHD 50 myeloproliferative diseases 50 pharmacokinetic PK study 50 diabetic peripheral neuropathy 50 glucocorticoid therapy 50 decompensated cirrhosis 50 candidemia 50 ORAL Solo 50 pilocytic astrocytoma 50 NAVISTAR R 50 very badly Berlinschi 50 systemic invasive fungal 50 tumors GIST 50 glioblastoma multiforme GBM 50 underwent liver transplantation 50 non peptidic protease 50 GvHD 50 Polyneuropathy 50 Vingan 50 Morquio syndrome 50 chronic lymphocytic 50 Gleevec imatinib mesylate 50 biochemical relapse 50 Clot busting 50 Metastatic melanoma 50 cholangiocarcinoma 50 hematological disorders 50 remission induction 50 Successfully Completes Phase 50 hereditary degenerative 50 Pamidronate 50 EGFR mutation positive 50 JMML 50 anaphylaxis eg 50 CEQ# 50 Chronic myeloid leukemia 50 lumbar spinal stenosis LSS 50 MPGN 50 lymphoma Hodgkin lymphoma 50 skeletal muscle weakness 50 chronic lymphocytic leukemia CLL 50 Synta Announces 50 lymphoblastic leukemia 50 Syndrome LEMS 50 idiopathic pulmonary 50 Lou Gehrigs disease 50 EGFr humanized monoclonal antibody 50 multiple myeloma MM 50 metastatic squamous cell carcinoma 50 Chordoma 50 chemoembolization 50 acute myelogenous leukemia AML 50 confirmed osteoblastic metastatic 50 Archexin 50 Bosutinib 50 acute myeloid 50 perioperative morbidity 50 functional mitral regurgitation 50 intermittent claudication 50 Cell Lymphoma CTCL 50 HIV HCV coinfected 50 Metastatic breast cancer 50 cilengitide 50 GED aPC 50 recurrent GBM 50 Venous thromboembolism 50 lexidronam injection 50 ® bortezomib 50 PRT# 50 myelodysplasia 50 rituximab refractory 50 pleural mesothelioma 50 sunitinib Sutent ® 50 unresectable locally advanced 50 refractory cutaneous T 50 Moyamoya disease 50 cytomegalovirus infection 50 pathologic fractures 50 hematological cancers 50 aplastic anemia rare 50 glucocorticoid induced osteoporosis 50 cholangitis 50 stem cell engraftment 50 tolerability pharmacokinetics 50 polycystic ovarian disease 50 TNFerade TM 50 castration resistant prostate cancer 50 Renal Impairment 50 MD FACS FAAP 50 Clinical Trials Consortium 50 malignant neoplasm 50 acute myelocytic leukemia 50 Lou Gerhig disease 50 Peritoneal mesothelioma 50 Rigel R# 50 Cystinosis 50 Aplidin 50 NS5B polymerase 50 receiving TNF blockers 50 allogeneic bone marrow 50 Dr. Dial Jumaili 50 colorectal liver metastases 50 Suicidal tendencies 50 Curaxin CBLC# 50 Retinitis Pigmentosa RP 50 invasive lobular carcinoma 50 KRAS status 50 Oral Fingolimod 50 AbioCor implant 50 Kamada AAT 50 POTELLIGENT ® Technology 50 Hodgkin lymphoma NHL 50 BrachySil TM 50 surgical debulking 50 post herpetic neuralgia 50 bi lateral mastectomy 50 pediatric acute lymphoblastic 50 Fibromyalgia Syndrome FMS 50 Complicated Skin 50 Cojocaru correspondent 50 chemoradiation 50 recurrent Hodgkin 50 adjuvant radiation 50 NSF NFD 50 hematopoietic cancers 50 multiforme 50 Pleural mesothelioma 50 HGS#